JAK2 and neoplasm: Icaritin inhibits the IL‐6/JAK2/STAT3 pathway by blocking the phosphorylation of JAK2 and STAT3, which suppresses downstream gene expression, prevents STAT3 nuclear translocation, and reduces tumor cell proliferation.